| HOME >> BIOLOGY >> TECHNOLOGY |
Due to related parties-trade 164,280 25,612
Due to related parties-non-trade 508,344 496,806
Current portion of bank notes
payables 2,889 5,405
Total current liabilities 2,854,458 1,853,070
Long-term liabilities, less current
portion:
Unsecured loans payable 1,574,350 1,472,717
Bank notes payable 17,988 1,351
Long-term convertible notes
payable 2,058,625 2,365,962
Less: discount relating to
warrants (856,308) (1,371,446)
Long-term convertible notes
payable - net 1,202,317 994,516
Total long-term liabilities 2,794,655 2,468,584
Minority interest in a subsidiary 110,838 103,362
Shareholders' equity (deficiency)
Common stock - $0.001 par value
Authorized 200,000,000 shares.
Issued and outstanding
81,519,676 and 70,149,556 shares
at December 31, 2007 and 2006,
respectively 81,520 70,150
Preferred stock - $0.001 par
value
Authorized 20,000,000 shares,
none issued -- --
Additional paid-in capital 9,217,876 8,311,975
Stock-based compensation reserve (307,053) (523,468)
Deficit accumulated (11,074,522) (7,766,654)
Accumulated other comprehensive
income (2,592) 1,1
'/>"/>
| SOURCE Kiwa Bio-Tech Products Group Corporation Copyright©2008 PR Newswire. All rights reserved |